Brainstorm Cell Therapeutics Inc (BCLI) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	1.12M	899.00K	852.00K	762.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.45M	1.15M	1.39M	1.28M
Operating expense	2.57M	2.05M	2.24M	2.05M
Total operating expenses	2.57M	2.05M	2.24M	2.05M
Operating income	-2.57M	-2.05M	-2.24M	-2.05M
Other non operating income	-	-	-	-
EBT including unusual items	-2.90M	-2.11M	-2.43M	-2.13M
EBT excluding unusual items	-2.90M	-2.11M	-2.43M	-2.13M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-2.90M	-2.11M	-2.43M	-2.13M
Net profit margin	-	-	-	-
Earnings per share	-0.34	-0.19	-0.13	-0.19
Interest and investment income	-	-	-	-
Interest expense	-330.00K	-59.00K	-190.00K	-81.00K
Net interest expenses	-330.00K	-59.00K	-190.00K	-81.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.52M	-2.00M	-2.20M	-2.01M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance